• NNC-55–0396, Calcium Signaling, and Glioblastoma

  2026-10-07

  A 2024 study reports that NNC-55–0396 kills glioblastoma cells through a coupled process: calcium-dependent autophagy induction alongside late-stage autophagy blockade caused by lysosomal alkalinization. The findings refine how calcium signaling, ER stress, vacuolation, and defective cargo degradation can converge on tumor-cell death, while remaining primarily an in vitro mechanistic observation.

• S1P Signaling, Vascular Biology, and Neuronal Apoptosis

  2026-10-07

  Sphingosine-1-phosphate is a context-dependent lipid mediator involved in receptor signaling, vascular biology, cell survival, and inflammation. This overview compares established research uses with findings from a 2024 intracerebral hemorrhage study, emphasizing receptor specificity, evidence strength, provenance, and translational limitations.

• MPP7, EMT, and Polarity in Ovarian Cancer

  2026-10-06

  A 2024 study links elevated MPP7 with poor prognosis and aggressive phenotypes in epithelial ovarian cancer, proposing that MPP7 influences epithelial–mesenchymal transition through Wnt/β-catenin signaling. Its integrated use of public datasets, tumor-tissue staining, cell assays, polarity imaging, transcriptomics, and protein analysis provides a coherent mechanistic model, although the evidence remains primarily associative and in vitro.

• Staurosporine and Cell-State-Ready Cancer Research

  2026-10-05

  Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor widely used to study apoptosis and kinase signaling. This article examines how cryopreservation-related changes in THP-1 cell state can influence interpretation of Staurosporine responses, using a 2025 RSC study to define stronger evidence boundaries.

• MK-571 (L-660,711): Evidence and Limits

  2026-10-05

  MK-571 (L-660,711) is a research antagonist associated with cysteinyl leukotriene receptor 1 pharmacology and, in supplier materials, MRP1 inhibition. This overview separates vendor-reported activity from published evidence, examines conceptual applications in leukotriene-mediated inflammation research, and explains why findings from a 2026 quercetin–PEG 400 study should not be interpreted as direct evidence for MK-571.

• Annexin V-Cy5 Apoptosis Kit in Microglia

  2026-10-04

  The Annexin V-Cy5 Apoptosis Kit can help distinguish phosphatidylserine exposure from lysosomal dysfunction in microglia. This evidence-focused guide interprets its role in the reversible mestranol model without treating reduced lysosomal activity as proof of apoptosis.

• Tβ4, Notch/NF-κB, and Angiogenesis in CLI

  2026-10-03

  The 2020 study by Lv et al. connects thymosin-β4 with angiogenic responses in critical limb ischemia through coordinated Notch and NF-κB pathway activity. Its combined cell, animal, molecular, and inhibitor-based evidence supports a preclinical mechanism, while also leaving important questions about pathway ordering, physiological relevance, and translation to human disease.

• Linoleic Acid: Practical Assay Workflows

  2026-10-02

  Linoleic Acid (C18:2(9Z,12Z), SKU C3108) supports controlled studies of membrane biology, oxidative stress, erythrocyte injury, epithelial migration, and essential fatty-acid deficiency. It is suitable for freshly prepared solvent-based dosing and should not be used where a stable aqueous stock or prolonged storage of solutions is required.

• Staurosporine: A Redox-Aware Assay Strategy

  2026-10-01

  Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor with powerful applications in apoptosis and signaling research. This article presents a redox-aware assay framework connecting kinase perturbation with GCLC truncation, glutathione biology, and cataract research while defining critical interpretation limits.

• Dual Recombinase Tracing Rejects Mouse Neo-Oogenesis

  2026-10-01

  Xie, Zhou, and Zheng use complementary Cre-loxP and Dre-rox lineage-tracing systems to test whether postnatal ovarian cells generate new oocytes in mice. Across physiological aging and busulfan-induced ovarian injury, the study detected no labeled growing oocytes or metaphase II eggs, strengthening the conclusion that in vivo postnatal neo-oogenesis does not occur under the tested conditions.

• KN-62: A Calcium-to-Cell-Cycle Research Map

  2026-09-30

  Explore how KN-62, a selective CaMKII inhibitor, can help separate calcium-dependent signaling from downstream synaptic and cellular outcomes. This guide connects the compound’s biochemical profile with new assay strategies inspired by Neuroligin 1 proteolysis and social-memory research.

• Ciclesonide Research: Workflows and Optimization

  2026-09-30

  Ciclesonide offers a practical prodrug system for studying lung-selective glucocorticoid activation, receptor signaling, and airway inflammation. This guide converts its activation profile into reproducible cell and animal workflows while placing ERAD-hijacking findings in the correct comparative context.

• Tranexamic Acid in Fibrinolysis Workflows

  2026-09-29

  Use Tranexamic Acid to connect plasmin inhibition with clot-stability, cell-adhesion, and wound-material assays. This workflow highlights how an antifibrinolytic agent can support mechanistic fibrinolysis research while helping researchers interpret advanced dressing performance.

• SMYD2, miR-125b, and Drug Resistance in RCC

  2026-09-29

  This 2019 Theranostics study connects SMYD2 overexpression with clear cell renal cell carcinoma progression, miR-125b regulation, and P-glycoprotein-associated multidrug resistance. Its combination of patient prognostic analysis, epigenetic assays, drug-sensitivity testing, and xenograft validation provides a mechanistic framework for studying treatment resistance in RCC.

• TXNL1-Bound Proteasome: Structure and Stress Degradation

  2026-09-28

  The reference study uses cryo-electron microscopy to define how thioredoxin-like protein 1 (TXNL1) binds the human 19S proteasome and undergoes ubiquitin-independent degradation after metal- or metalloid-associated oxidative stress. Its structural and cellular evidence identifies a proteasome-binding interface involving PSMD1, PSMD4, and PSMD14, providing a mechanistic framework for stress-regulated turnover of an abundant cellular protein.

8092 records 1/540 page Next 12345 下5页 Last page